Adjuvant treatment with pegylated interferon alpha-2a versus low-dose interferon alpha-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial(aEuro)

DSpace Repository

Adjuvant treatment with pegylated interferon alpha-2a versus low-dose interferon alpha-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial(aEuro)

Author: Eigentler, T. K.; Gutzmer, R.; Hauschild, A.; Heinzerling, L.; Schadendorf, D.; Nashan, D.; Kiecker, F.; Becker, J.; Moll, I.; Richtig, E.; Pehamberger, H.; Kaufmann, R.; Vogt, T.; Berking, C.; Praxmarer, M.; Garbe, C.; Hölzle, E.; Pönitzsch, I.; Sunderkötter, C.; Pföhler, C.
Tübinger Autor(en):
Eigentler, Thomas Kurt
Garbe, Claus
Published in: Annals of Oncology (2016), Bd. 27, H. 8, S. 1625-1632
Verlagsangabe: Oxford Univ Press
Language: English
Full text: http://dx.doi.org/10.1093/annonc/mdw225
ISSN: 1569-8041
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)